Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;130(2):151-7.
doi: 10.1111/j.1365-2567.2010.03267.x. Epub 2010 Apr 6.

Photochemical approaches to T-cell activation

Affiliations
Review

Photochemical approaches to T-cell activation

Morgan Huse. Immunology. 2010 Jun.

Abstract

Despite decades of intensive research, T-cell activation has remained mysterious because of both the dizzying diversity of antigen recognition and the speed and comprehensiveness of the T-cell-receptor signalling network. Further progress will require new approaches and reagents that provide added levels of control. Photochemistry allows specific biochemical processes to be controlled with light and is well suited to mechanistic studies in complex cellular environments. In recent years, several laboratories have adopted approaches based on photoreactive peptide-major histocompatibility complex reagents in order to study T-cell activation and function with high precision. Here, I review these efforts and outline future directions for this exciting area of research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Photoactivatable and conditional peptide-major histocompatibility complex (pMHC). In photoactivatable pMHC (left), a photocleavable protecting group is placed on a peptide side chain that is required for high-affinity interaction with the T-cell receptor (TCR). UV irradiation cleaves off this group, yielding the agonist pMHC complex. In conditional pMHC (right), a photocleavable group is attached to a peptide bond within the peptide. UV irradiation cleaves the peptide in two, after which it dissociates from the MHC protein. Grey, MHC protein; green, peptide; cyan, photocaged side chain; magenta, photocleavable peptide bond.
Figure 2
Figure 2
A typical peptide-major histocompatibility complex (pMHC) photoactivation experiment. T cells bearing fluorescent signalling probes are attached to glass surfaces containing photoactivatable (photoact.) pMHC, and a portion of the surface is irradiated with focused ultraviolet (UV) light during an imaging experiment. Below, a time-lapse montage shows consecutive images of a single cell expressing signalling probes for diacylglycerol (DAG, green) and the microtubule-organizing centre (MTOC) (red). The time and region of UV irradiation is indicated by the purple and yellow circle. Accumulation of DAG at the irradiated region [imaged using total internal reflection fluorescence (TIRF) microscopy] precedes the re-orientation of the MTOC. Above, a schematic diagram is shown that corresponds generally to the images presented below. The UV irradiation event is indicated by a purple and yellow beam. The objective lens (Obj.) in the schematic indicates the perspective of the images below.
Figure 3
Figure 3
Applications of conditional peptide-major histocompatibility complex (pMHC) technology. Ultraviolet (UV) irradiation of conditional pMHC in the presence of rescue peptides leads to the formation of pMHC complexes containing the rescue peptides. This enables the rapid generation of pMHC tetramers that can be used for epitope discovery, immune monitoring, or T-cell selection. Grey, MHC protein; green and magenta, conditional ligand; rescue peptides are shown in different colours.

Similar articles

Cited by

References

    1. Kersh GJ, Kersh EN, Fremont DH, Allen PM. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity. 1998;9:817–26. - PubMed
    1. Maini MK, Reignat S, Boni C, Ogg GS, King AS, Malacarne F, Webster GJ, Bertoletti A. T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection. Eur J Immunol. 2000;30:3067–78. - PubMed
    1. Pantaleo G, Demarest JF, Schacker T, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci USA. 1997;94:254–8. - PMC - PubMed
    1. Gavioli R, Guerrini R, Masucci MG, Tomatis R, Traniello S, Marastoni M. High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes. FEBS Lett. 1998;421:95–9. - PubMed
    1. Gomez-Nunez M, Haro KJ, Dao T, et al. Non-natural and photo-reactive amino acids as biochemical probes of immune function. PLoS ONE. 2008;3:e3938. - PMC - PubMed

LinkOut - more resources